{
  "docId": "019de070-d3cd-70da-8da9-11fac56c0e6a",
  "docSlug": "a10c554cbe4a4cf1ea91fc4610f64010",
  "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 27 slides",
  "authorId": "neurobo-pharmaceuticals",
  "authorName": "NeuroBo Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 27,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The slide uses a Venn-like overlapping circle diagram to represent market segments.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-d3cd-70da-8da9-11fac56c0e6a/20",
  "deckHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a",
  "deckJsonHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a.json",
  "deckAnchorHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.455,
        "w": 0.902,
        "x": 0.049,
        "y": 0.257
      },
      "kind": "diagram",
      "text": "COVID-19 Hospitalized Patients (1M in U.S.)1; COVID-19 Infected Individuals (20M in U.S.)2; Prophylaxis Over 65 (55M in U.S.)3 Front Line Healthcare (16M in U.S.)4; National Stockpile (25% of U.S. population)",
      "attrs": null,
      "subkind": "venn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "846f49a5-7d97-4076-8523-a8031a74561a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.083,
        "w": 0.486,
        "x": 0.014,
        "y": 0.892
      },
      "kind": "source-note",
      "text": "1. COVID-19 Associated Hospitalization Surveillance Network (COVID-NET) Mar-Dec 2020\n2. Johns Hopkins Coronavirus Resource Center Mar-Dec 2020\n3. Statista: 16.5% of 331M\n4. Center for Economic and Policy Research (CEPR) April 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c2e118d-b634-41fe-ae58-c9811f71d42b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.085,
        "w": 0.276,
        "x": 0.058,
        "y": 0.038
      },
      "kind": "title",
      "text": "Potential Markets",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3c35827-1b09-45d2-b365-0cbb352eba07",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Venn diagram",
      "slug": "venn-diagram",
      "agent": null,
      "layer": "slide",
      "matchId": "0c272696-9193-4224-9abf-25a63943a4f5",
      "evidence": "diagram/venn: COVID-19 Hospitalized Patients (1M in U.S.)1; COVID-19 Infected Individuals (20M in U.S.)2; Prophylaxis Over 65 (55M in U.S.)3 Front Line Healthcare (16M in U.S.)4; National Stockpile (25% of U.S. population)",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "market-segmentation-pyramid",
      "slug": null,
      "matchId": "1527df6a-dec2-40dc-bb64-1dbe34191b14",
      "evidence": "The slide breaks down a total addressable market into specific, quantified segments.",
      "confidence": 0.7
    }
  ],
  "arcBeats": [
    {
      "to": 21,
      "from": 20,
      "beatId": "f1ac50f0-1239-4611-9f0b-b49a7853e321",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slides 20-21 discuss the potential markets for ANA001.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 19,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "4d1fee7d-fbfc-4063-8c37-031d72ba1bf2",
      "evidence": "Slide 19 discusses the changing landscape for COVID-19 treatment, and slide 20 highlights potential markets.",
      "position": 1,
      "objective": "Why is now the right time for ANA001?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}